Use of von willebrand factor and pharmaceutical formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6005077
SERIAL NO

08744646

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of von Willebrand Factor (vWF) with a prolonged biological half-life for the production of a preparation for stabilization of blood coagulation Factor VIII (FVIII:C) in a mammal. Additionally, a pharmaceutical preparation is provided comprising a biologically active FVIII:C/vWF complex with improved pharmokinetic properties, said complex containing a vWF with a prolonged biological half-life.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BAXTER AKTIENGESELLSCHAFT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Eibl, Johann Vienna, AT 116 1743
Schwarz, Hans-Peter Vienna, AT 143 1170
Turecek, Peter Klosterneuburg, AT 159 1387

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation